Kurt Harrington

Contact Details

Social Links

Kurt Harrington

Bio

>25 year biotech and pharmaceutical operational and commercial leader. Founder and CEO of Ventoux Biosciences a Delaware C-corporation with headquarters in San Diego, CA. Ventoux Bio seeks to revolutionize treatment for Palmar Fibromatosis (Dupuytren's disease) and related, under-served, chronic, debilitating, fibrotic diseases.

Education

Saint Joseph's University

Philadelphia, Pennsylvania, United States

MBA, 2006

Pharmaceutical Marketing

Western Michigan University

Kalamazoo, Michigan, United States

BS, 1997

Marketing

Professional Associations

Biotech Industry Organization (BIO)

2022 - Present

eShares, Inc. DBA Carta, Inc. (“Carta”) is registered with the U.S. Securities and Exchange Commission as a transfer agent. The services and information described in this communication are provided to you “as is” and “as available” without warranties of any kind, expressed, implied or otherwise, including but not limited to all warranties of merchantability, fitness for a particular purpose, or non-infringement.

Site by eConverse Media

Neither Carta nor any of its affiliates will be liable for any damages, including without limitation direct, indirect, special, punitive or consequential damages, caused in any way or arising from the use of the services or reliance upon the information provided in this communication or in connection with any failure of performance, error, omission, interruption, defect, delay in operation or transmission, computer virus or line or system failure. Carta offers certain brokerage services through its wholly owned broker-dealer subsidiary, Carta Capital Markets, LLC (Member: FINRA/SIPC). Contact: eShares, Inc. DBA Carta, Inc., 333 Bush Street, Floor 23, Ste. 2300, San Francisco, CA 94104.

Profile

Kurt Harrington

Contact Details

Social Links

Kurt Harrington

Bio

Education

Professional Associations

Featured Products

Legal

Contact Us